{
    "data": [
        {
            "id": "4743847",
            "type": "article",
            "attributes": {
                "publishOn": "2024-12-12T08:22:07-05:00",
                "isLockedPro": false,
                "commentCount": 0,
                "gettyImageUrl": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/645381867/image_645381867.jpg",
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Ashland: A Stable Stock Trading At 50% Discount To Its Intrinsic Value",
                "structuredInsights": "{ \"Key Takeaways\": [ \"Ashland is a diversified specialty chemicals stock trading at a 50% discount to intrinsic value, with potential for substantial growth.\", \"The company is venturing into the biotechnology segment, leveraging cutting-edge technology for cosmetic products.\", \"Ashland offers a TTM dividend yield of 2.01%, showcasing its commitment to shareholders despite not being the highest dividend stock.\", \"EPS showed resilience, surpassing $1 in Q2 2024, amidst challenging conditions in key industries.\", \"Target share price is $125.72, indicating a 58.3% upside potential.\", \"\\\"Ashland stock is a particularly good fit for growth investors who want to cover the biotechnology sector and cash-in dividend checks.\\\"\" ], \"Positives\": [ \"Ashland's entry into biotechnology and its innovative cosmetic products highlight growth potential.\", \"The stock offers a levered beta of 0.88, indicating less volatility compared to the market.\", \"A target share price of $125.72 suggests a commendable upside of 58.3%.\", \"\\\"The market has, at large, overlooked the potential of Ashland\u2019s Life Science unit which accounted for nearly 40% of its revenue in FY23.\\\"\" ], \"Concerns\": [ \"Ashland faces challenges with stagnant growth in key industries impacting its EPS.\", \"The company's average free cash flow of $600 million over three years may limit growth opportunities.\", \"Potential regulatory changes and tariffs could affect profitability.\", \"\\\"The only time, the tone of this article turned dull, was when its free cash flow was discussed.\\\"\" ], \"Catalysts\": [ \"Ashland's involvement in innovative research, particularly in skincare, acts as a major growth catalyst.\", \"Global beauty market growth presents opportunities for Ashland's Personal Care unit.\", \"Potential demand from pharmaceutical companies for Ashland's chemicals could drive future growth.\", \"\\\"One of the biggest reasons to put money in Ashland\u2019s stock is the company is well-balanced between delivering the numbers and testing the boundaries of life sciences.\\\"\" ] }",
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "107728",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "589421",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "3112",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4743847-ashland-a-stable-stock-trading-at-50-percent-discount-to-its-intrinsic-value"
            }
        }
    ]
}